Bottom line
What is NARCX's expense ratio?
NARCX's expense ratio is 2.28%, or about $228 a year on every $10,000 invested. That is more expensive than 99% of international stock funds we track (median 0.9%). It has no front-end sales load. Its expense ratio includes a 1% 12b-1 marketing fee.
Updated Feb 25, 2026
NARCX fee table
| Net expense ratio | 2.28% |
|---|---|
| Gross expense ratio | 2.3% |
| Management fee | 1% |
| 12b-1 (distribution) fee | 1% |
| Other expenses | 0.3% |
| Fee waiver / reimbursement | -0.02% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 1% |
Source: Fund prospectus fee table, filed Feb 25, 2026
What NARCX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| NARCX | $331 | $716 | $1,228 | $2,634 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 2.28% expense ratio costs roughly $113,100 in lost growth, versus about $50,300 for the median international stock fund (0.9%).